Mirae Asset Global Investments Co., Ltd. Roivant Sciences Ltd. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 24,258 shares of ROIV stock, worth $259,075. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,258
Previous 26,747
9.31%
Holding current value
$259,075
Previous $308,000
7.14%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ROIV
# of Institutions
329Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$703 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$663 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$511 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$471 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$378 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.52B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...